These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 22279537)
1. Novel bacterial metabolite merochlorin A demonstrates in vitro activity against multi-drug resistant methicillin-resistant Staphylococcus aureus. Sakoulas G; Nam SJ; Loesgen S; Fenical W; Jensen PR; Nizet V; Hensler M PLoS One; 2012; 7(1):e29439. PubMed ID: 22279537 [TBL] [Abstract][Full Text] [Related]
2. Biosynthetically Guided Structure-Activity Relationship Studies of Merochlorin A, an Antibiotic Marine Natural Product. López-Pérez B; Pepper HP; Ma R; Fawcett BJ; Pehere AD; Wei Q; Ji Z; Polyak SW; Dai H; Song F; Abell AD; Zhang L; George JH ChemMedChem; 2017 Dec; 12(23):1969-1976. PubMed ID: 29168322 [TBL] [Abstract][Full Text] [Related]
3. In vitro bactericidal activity of levonadifloxacin (WCK 771) against methicillin- and quinolone-resistant Staphylococcus aureus biofilms. Tellis M; Joseph J; Khande H; Bhagwat S; Patel M J Med Microbiol; 2019 Aug; 68(8):1129-1136. PubMed ID: 31241446 [TBL] [Abstract][Full Text] [Related]
4. Activity of the thiopeptide antibiotic nosiheptide against contemporary strains of methicillin-resistant Staphylococcus aureus. Haste NM; Thienphrapa W; Tran DN; Loesgen S; Sun P; Nam SJ; Jensen PR; Fenical W; Sakoulas G; Nizet V; Hensler ME J Antibiot (Tokyo); 2012 Dec; 65(12):593-8. PubMed ID: 23047246 [TBL] [Abstract][Full Text] [Related]
5. Staphylococcal Bacterial Persister Cells, Biofilms, and Intracellular Infection Are Disrupted by JD1, a Membrane-Damaging Small Molecule. Dombach JL; Quintana JLJ; Detweiler CS mBio; 2021 Oct; 12(5):e0180121. PubMed ID: 34634935 [TBL] [Abstract][Full Text] [Related]
6. Delafloxacin activity against Staphylococcus aureus with reduced susceptibility or resistance to methicillin, vancomycin, daptomycin or linezolid. Saravolatz LD; Pawlak JM; Wegner C J Antimicrob Chemother; 2020 Sep; 75(9):2605-2608. PubMed ID: 32542310 [TBL] [Abstract][Full Text] [Related]
7. Novel Daptomycin Tolerance and Resistance Mutations in Methicillin-Resistant Staphylococcus aureus from Adaptive Laboratory Evolution. Sulaiman JE; Lam H mSphere; 2021 Oct; 6(5):e0069221. PubMed ID: 34585959 [TBL] [Abstract][Full Text] [Related]
8. Telavancin demonstrates activity against methicillin-resistant Staphylococcus aureus isolates with reduced susceptibility to vancomycin, daptomycin, and linezolid in broth microdilution MIC and one-compartment pharmacokinetic/pharmacodynamic models. Smith JR; Barber KE; Hallesy J; Raut A; Rybak MJ Antimicrob Agents Chemother; 2015 Sep; 59(9):5529-34. PubMed ID: 26124162 [TBL] [Abstract][Full Text] [Related]
9. In vitro activity of fosfomycin alone and in combination against Staphylococcus aureus with reduced susceptibility or resistance to methicillin, vancomycin, daptomycin or linezolid. Saravolatz LD; Pawlak J J Antimicrob Chemother; 2022 Dec; 78(1):238-241. PubMed ID: 36374572 [TBL] [Abstract][Full Text] [Related]
10. Association of mprF mutations with cross-resistance to daptomycin and vancomycin in methicillin-resistant Staphylococcus aureus (MRSA). Thitiananpakorn K; Aiba Y; Tan XE; Watanabe S; Kiga K; Sato'o Y; Boonsiri T; Li FY; Sasahara T; Taki Y; Azam AH; Zhang Y; Cui L Sci Rep; 2020 Sep; 10(1):16107. PubMed ID: 32999359 [TBL] [Abstract][Full Text] [Related]
11. [Comparative activity of daptomycin against clinical isolates of methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococci]. Picazo JJ; Betriu C; Rodríguez-Avial I; Culebras E; López F; Gómez M; Enferm Infecc Microbiol Clin; 2010 Jan; 28(1):13-6. PubMed ID: 19406529 [TBL] [Abstract][Full Text] [Related]
12. In vitro effect of the presence of human albumin or human serum on the bactericidal activity of daptomycin against strains with the main resistance phenotypes in Gram-positives. Cafini F; Aguilar L; González N; Giménez MJ; Torrico M; Alou L; Sevillano D; Vallejo P; Prieto J J Antimicrob Chemother; 2007 Jun; 59(6):1185-9. PubMed ID: 17412725 [TBL] [Abstract][Full Text] [Related]
13. Marine bacteria: potential sources for compounds to overcome antibiotic resistance. Eom SH; Kim YM; Kim SK Appl Microbiol Biotechnol; 2013 Jun; 97(11):4763-73. PubMed ID: 23640363 [TBL] [Abstract][Full Text] [Related]
14. The tigecycline evaluation and surveillance trial; assessment of the activity of tigecycline and other selected antibiotics against gram-positive and gram-negative pathogens from France collected between 2004 and 2016. Decousser JW; Woerther PL; Soussy CJ; Fines-Guyon M; Dowzicky MJ Antimicrob Resist Infect Control; 2018; 7():68. PubMed ID: 29876099 [TBL] [Abstract][Full Text] [Related]
15. [In vitro activity of daptomycin against VRE and MRSA strains]. Aktaş G; Derbentli S Mikrobiyol Bul; 2014 Jan; 48(1):123-8. PubMed ID: 24506722 [TBL] [Abstract][Full Text] [Related]